Accumulation of imidazolone, pentosidine and Nɛ‐(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain
- 1 September 2002
- journal article
- Published by Wiley in Pathology International
- Vol. 52 (9) , 563-571
- https://doi.org/10.1046/j.1320-5463.2002.01390.x
Abstract
Previous studies from our laboratory demonstrated that Nɛ‐(carboxymethyl)lysine (CML), one of the major advanced glycation end products (AGE), was accumulated in human pyramidal neurons in the hippocampus in an age‐dependent manner. This suggests a potential link between AGE‐accumulation and the aging process in neurons. The purpose of the present study was to examine whether this notion could be extended to other AGE structures, such as imidazolone and pentosidine. This was done using 19 human brains that were not affected by dementia. The immunohistochemical survey on distribution in brain tissues of imidazolone and pentosidine was carried out with monoclonal antibodies specific for imidazolone and pentosidine. A parallel control experiment was carried out with anti‐CML antibody. The results showed that pentosidine and imidazolone were localized in neurons in different areas of human brain tissue, especially in neurons of CA4 in the hippocampus. The characteristic distribution of pentosidine and imidazolone is very similar to that of CML. Furthermore, when the accumulation of these AGE structures was compared with the age of individual brains it was found that accumulation of imidazolone, pentosidine and CML in the CA4 region increased with age. These findings taken together support the notion that the accumulation of AGE structures in the CA4 region might be closely related to the aging process in neurons.Keywords
This publication has 46 references indexed in Scilit:
- Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End ProductsJournal of Biological Chemistry, 2001
- Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative DiseasesThe American Journal of Pathology, 1998
- Localization of identified advanced glycation end‐product structures, Nε=(carboxymethyl)lysine and pentosidine, in age‐related inclusions in human brainsPathology International, 1998
- Immunohistochemical Localization of Advanced Glycation End Products, Pentosidine, and Carboxymethyllysine in Lipofuscin Pigments of Alzheimer's Disease and Aged NeuronsBiochemical and Biophysical Research Communications, 1997
- Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptideBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brainNeuroscience Letters, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Age-dependent accumulation of advanced glycosylation end products in human neuronsNeurobiology of Aging, 1995
- Slow Axonal Transport Impairment of Cytoskeletal Proteins in Streptozociti-Induced Diabetic NeuropathyJournal of Neurochemistry, 1989
- Superoxide production from nonenzymatically glycated proteinFEBS Letters, 1988